FDA adds brain tumor warning to Depo-Provera label for Pfizer’s birth control injections after studies link the drug to meningioma risk.
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. DEPO-PROVERA contains the active ingredient medroxyprogesterone ...
FDA approves Depo-Provera label warning of meningioma brain tumor risk after 1983 studies; 1,000+ women sue Pfizer for concealment as EMA, Canada already updated labels., US News, Times Now ...
While there are many forms of birth control that use progestin, "no increased meningioma risk has been found with combined ...
Depo Provera’s label change comes amidst a flurry of over 2,000 lawsuits from women alleging that the contraceptive caused ...
The New York Times recently gave front-page, above-the-fold treatment to an article by Pam Belluck concerning the doubled risk of HIV acquisition among couples using the injectable contraceptive Depo ...
Provera’s label to include a warning about meningioma, a type of brain tumour. The change follows studies and a lawsuit alleging Pfizer knew of the risk but didn’t warn patients.
With thousands of lawsuits and growing concerns over long-term risks, the FDA have added a brain tumor warning to the drug's label.